Works matching DE "OCATA Therapeutics Inc."
1
- Hastings Center Report, 2002, v. 32, n. 3, p. 27, doi. 10.2307/3528111
- GREEN, RONALD M.;
- DEVRIES, KIER OLSEN;
- BERNSTEIN, JUDITH;
- GOODMAN, KENNETH W.;
- KAUFMANN, ROBERT;
- KIESSLING, ANN A.;
- LEVIN, SUSAN R.;
- MOSS, SUSAN L.;
- TAUER, CAROL A.
- Article
2
- JAMA: Journal of the American Medical Association, 2006, v. 296, n. 14, p. 1720, doi. 10.1001/jama.296.14.1720-b
- Article
3
- Ocular Surgery News, 2010, v. 28, n. 8, p. 50
- Article
4
- Expert Review of Ophthalmology, 2006, v. 1, n. 1, p. 13
- Article
5
- Nature, 2012, v. 481, n. 7382, p. 414, doi. 10.1038/481414a
- Article
6
- Nature, 2012, v. 481, n. 7380, p. 130, doi. 10.1038/481130a
- Article
7
- Nature, 2011, v. 475, n. 7356, p. 270, doi. 10.1038/475270a
- Article
8
- Nature Reviews Molecular Cell Biology, 2002, v. 3, n. 1, p. 7, doi. 10.1038/nrm708
- Article
9
- Nature Genetics, 2000, v. 26, n. 3, p. 261
- Article
11
- Nature Reviews Drug Discovery, 2006, v. 5, n. 10, p. 808, doi. 10.1038/nrd2170
- Article
12
- Nature Biotechnology, 2013, v. 31, n. 6, p. 483, doi. 10.1038/nbt.2602
- Article
13
- Nature, 2002, v. 417, n. 6887, p. 370, doi. 10.1038/417370b
- Article
14
- Nature, 2001, v. 413, n. 6854, p. 339, doi. 10.1038/35096722
- Abbott, Alison;
- Cyranoski, David
- Article
15
- Chemistry & Industry, 2014, v. 78, n. 3, p. 46, doi. 10.1002/cind.783_15.x
- Article
16
- Nature, 2006, v. 439, n. 7077, p. 658, doi. 10.1038/439658a
- Article
17
- Human Life Review, 2001, v. 27, n. 4, p. 7
- Article
18
- Nature Biotechnology, 2002, v. 20, n. 1, p. 1, doi. 10.1038/nbt0102-1
- Article
19
- Nature Biotechnology, 2002, v. 20, n. 1, p. 4, doi. 10.1038/nbt0102-4
- Article